Similarly, a previous report showed that constitutive inhibition of PTEN expression in BT474 cells triggers the activation of an IL-6 inflammatory loop via the JAK–STAT3 axis that is critical in mediating treatment resistance in HER2-positive breast cancer by expanding the cancer stem cell population [26]. Here, ERBB2 is linked to breast cancer.